| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| JZL184抑制剂 | 4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate | 1101854-58-3 | C27H24N2O9 |
| JZL-195抑制剂 | (4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate | 1210004-12-8 | C24H23N3O5 |
| JWH073丁酸代谢物 | 4-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]butanoic acid | 1307803-52-6 | C23H19NO3 |
| JWH0187-羟基吲哚代谢物 | (7-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 1307803-45-7 | C24H23NO2 |
| JWH-398((4-氯萘-1-基)(1-pentylindol-3-基)甲酮)标准品 | JWH-398 | 1292765-18-4 | C24H22ClNO |
| JWH-1225-羟基戊基 | JWH-122 N-(5-hydroxypentyl)metabolite | 1379604-68-8 | C25H25NO2 |
| JWH-0732-羟基吲代谢物 | JWH 073 2-hydroxyindole metabolite | 1427325-54-9 | C23H21NO2 |
| JWH-072-N-羧酸 | JWH 018 N-propanoic acid metabolite | 1451369-32-6 | C22H17NO3 |
| JWH-018omega-羟基戊基 | JWH-018 N-(5-Hydroxypentyl) | 335161-21-2 | C24H23NO2 |
| JWH-018N-戊基-5-羧酸 | 5-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]pentanoic acid | 1254475-87-0 | C24H21NO3 |
| JWH-0184-羟基戊基代谢物标准品 | (1-(4-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 1320363-47-0 | C24H23NO2 |
| JWH 251 4-甲基苯基异构体 | 2-(4-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone | 864445-41-0 | C22H25NO |
| JWH 203 3-氯异构体 | JWH 237 | 864445-56-7 | C21H22ClNO |
| JPM 565 乙基酯 | [125I]-JPM-OEt | 262381-84-0 | C20H28N2O6 |
| JP1302二盐酸盐 | MMV006172 | 80259-18-3 | C24H24N4 |
| JNK抑制剂II,阴性对照 | JNK Inhibitor II, Negative Control | 54642-23-8 | C15H10N2O |
| JNK抑制剂(BI-78D3) | 4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one | 883065-90-5 | C13H9N5O5S2 |
| JNJ-40346527游离态 | 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide | 1142363-52-7 | C27H35N5O2 |
| JNJ 5207787; 反式-N-(1-乙酰基-2,3-二氢-1H-吲哚-6-基)-3-(3-氰基苯基)-N-[1-(2-环戊基乙基)哌啶-4-基]丙烯酰胺 | trans-N-(1-acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]acrylamide | 683746-68-1 | C32H38N4O2 |
| JNJ 3026582; 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 | RWJ67657 | 215303-72-3 | C27H24FN3O |
| JDTic;(3R)-1,2,3,4-四氢-7-羟基-N-[(1S)-1-[[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基]-2-甲基丙基]-3-异喹啉甲酰胺 | (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide | 361444-66-8 | C28H39N3O3 |
| JAK激酶抑制剂 | Peficitinib hydrobromide | 1353219-05-2 | C18H23BrN4O2 |
| JAK2抑制剂V,Z3 | NSC 42834 | 195371-52-9 | C23H24N2O |
| I型P21激活激酶(PAK)抑制剂(FRAX597) | FRAX597 | 1286739-19-2 | C29H28ClN7OS |
| I咪达那新杂质(N-(3氨基甲酰基3,3-DIPHENYLPROPYL)-OXAMIC酸) | N-(3-carbamoyl-3,3-diphenylpropyl)oxamic acid | 503598-07-0 | C18H18N2O4 |
| Ivacaftor苯磺酸盐 | N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide.besylate | 1134822-09-5 | C6H6O3S*C24H28N2O3 |
| Isoboonein; (4aR,6S,7R,7aS)-六氢-6-羟基-7-甲基环戊并[c]吡喃-3(1H)-酮 | isoboonein | 99946-04-0 | C9H14O3 |
| Isoboonein acetate; (4aR,6S,7R,7aS)-6-(乙酰氧基)六氢-7-甲基环戊并[c]吡喃-3(1H)-酮 | Isoboonein acetate | 99891-77-7 | C11H16O4 |
| Isobonducellin; (3Z)-2,3-二氢-7-羟基-3-[(4-甲氧基苯基)亚甲基]-4H-1-苯并吡喃-4-酮 | (Z)-7-hydroxy-3-(4'-methoxybenzylidene)chroman-4-one | 610778-85-3 | C17H14O4 |
| Ipragliflozin; (1S)-1,5-脱水-1-C-[3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基]-D-葡糖醇 | ipragliflozin | 761423-87-4 | C21H21FO5S |
| Im-bzl-L-组氨酸甲酯 | N'-benzyl-L-histidine methyl ester | 19817-75-5 | C14H17N3O2 |
| Idasanutlin(4-((2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-新戊基吡咯烷-2-甲酰胺)-3-甲氧基苯甲酸;) | idasanutlin | 1229705-06-9 | C31H29Cl2F2N3O4 |
| IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 | N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide | 686770-61-6 | C22H18N4O2S3 |
| IU1抑制剂 | 1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one | 314245-33-5 | C18H21FN2O |
| ITI214自由基 | (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one | 1160521-50-5 | C29H26FN7O |
| IS(+)-3-溴樟脑-10-磺酸 | ((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate | 206860-46-0 | C10H17BrO5S |
| IRTK激活剂,负控制 | 3,6-dihydroxy-2-(4-methoxyphenyl)-5-phenyl-1,4-benzoquinone | 6172-50-5 | C19H14O5 |
| IRE1抑制剂(STF-083010) | N-[(2-hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide | 307543-71-1 | C15H11NO3S2 |
| IRAK抑制剂5;3-硝基-N-[1-(3-羟基丙基)-5-(2,2-二甲基丙酰基氧基)-1H-苯并咪唑-2-基]苯甲酰胺 | 1-(3-Hydroxypropyl)-2-[(3-Nitrobenzoyl)amino]-1h-Benzimidazol-5-Yl Pivalate | 509093-60-1 | C22H24N4O6 |
| IRAK-1-4 抑制剂 I | IRAK-1/4 Inhibitor | 509093-47-4 | C20H21N5O4 |
| IRAK 抑制剂 6; N-[2-甲氧基-4-(4-吗啉基)苯基]-2-(3-吡啶基)-4-噻唑甲酰 | IRAK inhibitor 6 | 1042672-97-8 | C20H20N4O3S |
| IR-797氯化物 | IR-797 chloride | —— | C31H34ClN2*Cl |
| IR-780 碘化物 | IR-780 | 207399-07-3 | C36H44ClN2*I |
| IR-775 氯化物 | IR-775 chloride | 199444-11-6 | C32H36ClN2*Cl |
| IR-1048四氟硼酸盐 | 1-(2,6-dimethylphenyl)-3-(3-propanol)thiourea | 120077-91-0 | C12H18N2OS |
| IPI145中间体-5 | 8-chloro-2-phenyl-3-((1S)-1-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one | 1350643-73-0 | C27H25ClN6O2 |
| IPI-926盐酸盐 | N-[(3R,3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridin-4-ium]-3-yl]methanesulfonamide;chloride | 1169829-40-6 | C29H48N2O3S*ClH |
| IPI-549,一种有效的选择性PI3KΓ抑制剂 | IPI-549 | 1693758-51-8 | C30H24N8O2 |
| IPDI二乙基己酯 | monoderm I-8 | 185568-15-4 | C28H54N2O4 |
| IPDI二丁基己酯 | Carbamic acid, (3-((((isodecyloxy)carbonyl)amino)methyl)-3,5,5-trimethylcyclohexyl)-, isodecyl ester | 185568-16-5 | C32H62N2O4 |